Filing summary
Helus Pharma Inc. filed a Form 6-K as a foreign private issuer for October 2026. The report was signed on October 1, 2026 by Chief Financial Officer Greg Cavers. The filing indicates the company files annual reports on Form 40-F.
Financial and operating information
The supplied filing text contains no financial statements, operating results, cash flow, liquidity, debt, margins, guidance, or management commentary. It does not provide a clear value for any financial metric.
Changes, risks, and unusual items
The exhibit index lists Exhibit 99.1, a news release dated October 1, 2026, but the release itself is not included in the supplied text. No material changes, risks, contingencies, or unusual items can be assessed from this text.
Facts to verify
- Obtain and review Exhibit 99.1 for the news release and any associated financial or business disclosures.
- Confirm whether the release includes material updates, guidance, risks, or other information not shown in this filing text.